It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability, shows differences in prevalence, severity and age of onset among different ancestral groups. Previous genetic studies have focused more on European populations, which appear to be the least affected. Consequently, the genetic variations that underlie the commonalities, differences and treatment options in SLE among ancestral groups have not been well elucidated. To address this, we undertake a genome-wide association study, increasing the sample size of Chinese populations to the level of existing European studies. Thirty-eight novel SLE-associated loci and incomplete sharing of genetic architecture are identified. In addition to the human leukocyte antigen (HLA) region, nine disease loci show clear ancestral differences and implicate antibody production as a potential mechanism for differences in disease manifestation. Polygenic risk scores perform significantly better when trained on ancestry-matched data sets. These analyses help to reveal the genetic basis for disparities in SLE among ancestral groups.
The presentation of systemic lupus erythematosus has been known to differ by ancestry, but the underlying genetic factors remain unclear. Here, the authors report ancestry-specific susceptibility loci and better risk prediction when using data from matched ancestral groups.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 The University of Hong Kong, Department of Paediatrics and Adolescent Medicine, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)
2 Guangzhou Medical University, Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children’s Medical Center, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072)
3 The Third Affiliated Hospital of Sun Yat-Sen University, Department of Rheumatology, Guangzhou, China (GRID:grid.412558.f) (ISNI:0000 0004 1762 1794)
4 The University of Hong Kong, Department of Paediatrics and Adolescent Medicine, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757); University of Minnesota, The Hormel Institute, Austin, USA (GRID:grid.17635.36) (ISNI:0000000419368657)
5 King’s College London, Division of Genetics and Molecular Medicine, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
6 Anhui Medical University, Department of Dermatology, No.1 Hospital, Hefei, China (GRID:grid.186775.a) (ISNI:0000 0000 9490 772X)
7 Guangdong Provincial People’s Hospital, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangzhou, China (GRID:grid.413405.7) (ISNI:0000 0004 1808 0686)
8 Guangzhou Women and Children’s Medical Center, Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou, China (GRID:grid.413428.8) (ISNI:0000 0004 1757 8466)
9 The University of Hong Kong, School of Public Health, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)
10 The University of Hong Kong, School of Public Health, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757); National Institutes of Health, Radiation Epidemiology Branch, Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
11 Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Rheumatology, Renji Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
12 Union Hospital Affiliated to Fujian Medical University, Department of Pediatrics, Fuzhou, China (GRID:grid.411176.4) (ISNI:0000 0004 1758 0478)
13 Affiliated Hospital of Jining Medical University, Department of Rheumatology, Jining, China (GRID:grid.452252.6) (ISNI:0000 0004 8342 692X)
14 Affiliated Hospital of Jining Medical University, Department of Endocrinology, Jining, China (GRID:grid.452252.6) (ISNI:0000 0004 8342 692X)
15 Tuen Mun Hospital, Department of Medicine, Hong Kong, China (GRID:grid.417336.4) (ISNI:0000 0004 1771 3971)
16 China-Japan Friendship Hospital, Department of Dermatology, Chaoyang, China (GRID:grid.415954.8) (ISNI:0000 0004 1771 3349)
17 The University of Hong Kong, Department of Psychiatry, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)
18 The University of Hong Kong, Department of Medicine, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)
19 The University of Hong Kong, Department of Paediatrics and Adolescent Medicine, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757); The University of Hong Kong, Shenzhen Institute of Research and Innovation, Hong Kong, China (GRID:grid.194645.b) (ISNI:0000000121742757)